Esperion Logo (primary).png
Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Third Quarter 2016 Financial Results
November 03, 2016 16:05 ET | Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Nov. 03, 2016 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), a pharmaceutical company focused on developing and commercializing oral therapies for the treatment...
Vocera Announces Third Quarter Revenue of $33.8 million and Raises FY’16 Revenue Guidance
October 27, 2016 16:06 ET | Vocera Communications
SAN JOSE, Calif., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Vocera Communications, Inc. (NYSE:VCRA), the leading healthcare communications company, today reported total revenue of $33.8 million, an...
Vocera Q3 2016 Results to be Released October 27, 2016
October 13, 2016 08:00 ET | Vocera Communications
SAN JOSE, Calif., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Vocera Communications, Inc. (NYSE:VCRA) today announced that it expects to release results for its third quarter 2016 on Thursday, Oct. 27,...
Lexington Realty Trust to Report Third Quarter 2016 Financial Results on November 3, 2016
October 11, 2016 16:20 ET | Lexington Realty Trust
NEW YORK, Oct. 11, 2016 (GLOBE NEWSWIRE) -- Lexington Realty Trust (NYSE:LXP) (“Lexington”), a real estate investment trust (REIT) focused on single-tenant real estate investments, today announced...